Safety and immunogenicity of booster vaccination and fractional dosing with Ad26 COV2S or BNT162b2 in Ad26COV2Svaccinated participants

C RiouJinal BhimanY GangaShobna SawryFrances AyresR BagumaSashkia BallaE et alNelia ManamelaFaeezah PatelThandeka Moyo-GweteSimone RichardsonVera ReesPenelope MooreLee Fairlie2024-12-172024-12-17DOAJhttps://hdl.handle.net/10539/43351Safety and immunogenicity of booster vaccination and fractional dosing with Ad26 COV2S or BNT162b2 in Ad26COV2Svaccinated participantsJournal Article